INBX - Inhibrx, Inc. -  [ ]

Seasonality of Returns By Period

Average daily return by calendar bucket (ClosePriceSA).

Day of Week

Week of Month

Month of Year

Seasonal Path

YTD vs Last Year vs Lookback Avg · closes rebased to 100 at each year's first session
Ticker Details
Inhibrx, Inc.
IPO Date: August 19, 2020
Sector: Healthcare
Industry: Biotech
Market Cap: $1.37B
Activated in VL: True
Average Daily Range
Avg Daily Range: $1.21 | 3.71%
Avg Daily Range (30 D): $2.58 | 2.36%
Avg Daily Range (90 D): $2.75 | 2.80%
Institutional Daily Volume
Avg Daily Volume: .25M
Avg Daily Volume (30 D): .25M
Avg Daily Volume (90 D): .23M
Trade Size
Avg Trade Size (Sh.): 59
Avg Trade Size (Sh.) (30 D): 38
Avg Trade Size (Sh.) (90 D): 38
Institutional Trades
Total Institutional Trades: 1,704
Avg Institutional Trade: $2.37M
Avg Institutional Trade (30 D): $3.21M
Avg Institutional Trade (90 D): $3.29M
Avg Institutional Trade Volume: .07M
Avg Institutional Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $2.41M
Avg Closing Trade (30 D): $4.32M
Avg Closing Trade (90 D): $3.82M
Avg Closing Volume: 67.98K
 
News
Sep 1, 2026 @ 5:00 PM
Chondrosarcoma Clinical Trial Pipeline: Emerging T...
Source: Delveinsight
May 14, 2026 @ 8:02 PM
Inhibrx Reports First Quarter 2026 Financial Resul...
Source: Prnewswire
Apr 22, 2026 @ 6:20 PM
Large Drugmakers Eye Inhibrx Cancer Drugs Valued O...
Source: Vandana Singh
Oct 24, 2025 @ 5:22 PM
Stocks Soar To Records After Weak Inflation, Ford ...
Source: Piero Cingari
Oct 24, 2025 @ 7:05 AM
Why Are Inhibrx Biosciences Shares Soaring 76% Aft...
Source: Mohd Haider
Financials
  TTM Q2 2026 Q1 2026
Basic EPS $-8.88 $-2.34 $-2.15
Diluted EPS $-8.88 $-2.34 $-2.15
Revenue $M $M $M
Gross Profit
Net Income / Loss $-138.18M $-36.65M $-33.44M
Operating Income / Loss $-127.81M $-32.15M $-30.93M
Cost of Revenue
Net Cash Flow $-62.35M $M $M
PE Ratio